December 20, 2021

FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®

MELBOURNE, Australia and INDIANAPOLIS, Dec. 20, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the development of diagnostic and therapeutic products based on molecularly targeted radiation (MTR), today announces that the United States Food and Drug Administration (FDA) has approved Telix’s

Read More

MAPIM channels aid to flood victims in Klang

KUALA LUMPUR, Dec 20 — Malaysian Consultative Council for Islamic Organisation (MAPIM) has mobilised its machinery to deliver aid to victims affected by the floods that hit Klang since last Saturday.Yesterday, in collaboration with its main wing, MAPI…

Read More